Navigation Links
Generex Oncology Receives New Patent for AE37 Immunotherapeutic Cancer Vaccine
Date:2/3/2011

WORCESTER, Mass., Feb. 3, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT), together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, Inc. (www.antigenexpress.com), announced today that Antigen Express has received a Notice of Allowance from the United States Patent Office relating to an application making augmentative pharmaceutical composition claims for the Antigen Express AE37 immunotherapeutic cancer vaccine.  The Company has previously received allowances of broad claims surrounding its Ii-Key hybrid technology, which was used in the design of the AE37 vaccine platform.  The current allowance strengthens independent composition of matter claims directed to the AE37 peptide. The full term of the new patent will extend through January 5, 2028.

(Logo: http://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b)

AE37 is currently the subject of a randomized and controlled Phase II efficacy study in patients treated for breast cancer who are at high risk of recurrence.  Favorable results from this study have been reported previously.  This immunotherapeutic vaccine also has been tested in a Phase I study in patients with prostate cancer, which confirmed the safety and immunogenicity observed in the prior breast cancer study.  In addition to breast and prostate cancer, many other types of cancer, such as lung, colon, stomach and bladder, also express the HER2 protein, which is the target for an AE37 stimulated immune response.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies.  Generex has developed a proprietary platform technology for the delivery of drugs i
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
2. Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology in the Development of Therapeutic Vaccines for Cancer
3. Generex Announces Extension of Global Medical Direct Acquisition Closing Date
4. Generex Receives New Patent for Buccal Drug Delivery Platform Technologies
5. Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal
6. Generex Oncology Awarded Two IRS Therapeutic Discovery Project Grants
7. Generex Common Stock Now Quoted on the Over-the-Counter Bulletin Board
8. Generex to Participate in Canadian Diabetes Association Conference
9. Generex Reschedules Live Video Webcast
10. Generex Announces Approval of Adjournment Proposal and Adjourned Special Meeting Date
11. Generex Announces That Adjournment Will be Sole Matter Considered at Reconvened Special Meeting of Stockholders on October 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... August 3, 2015 Global ... to reach USD 24.7 billion by 2022, according ... Inc. Growing prevalence of neurological and musculoskeletal disorders ... over the forecast period. The presence of efficient ... advancement in the technologies coupled with implementation of ...
(Date:8/3/2015)... 3, 2015 Cooperative ... military surgical research and top-tier universities for ... to severe wound treatments for critical-care patients ... medicine and tissue-engineered skin substitute advancements.  Biotech ... in focus are Amarantus Bioscience Holdings, Inc. ...
(Date:8/3/2015)... 2015  Dr. Cal Robinson , Psy.D., ... Center today, providing patients with new methods ... through psychological counseling and treatment programs. ... medical psychologist with an extensive career in pain ... from assessment and treatment of behavioral medicine disorders ...
Breaking Medicine Technology:Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 2Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 3Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 4Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 5Biotech Advancements Coupled with Collaborative Partnerships Focus on Developing Orphan Drug Products & Treatments for Critical-Care Patients With Severe Wound Conditions 6Orthopaedic & Spine Center Introduces New Pain Psychologist 2
... Calif., March 30, 2011 Isis Pharmaceuticals, Inc. (Nasdaq: ... that management will present a company overview at Needham,s 10th ... a.m. ET at the New York Palace Hotel. ... on the "Investors & Media" section of the Company,s Web ...
... LONDON, March 30, 2011 Silence Therapeutics plc (AIM: ... interference (RNAi) therapeutics company, announces that interim data from ... Company,s lead internal therapeutic candidate, have been accepted for ... Oncology ("ASCO") Annual Meeting.  The meeting will take place ...
Cached Medicine Technology:Silence Therapeutics' Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting 2Silence Therapeutics' Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting 3
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today welcomed the announcement by OPKO Health that ... Application for a new treatment for chronic kidney disease (CKD) and vitamin D ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... retailer of nutritional supplements, has officially opened the polls for their eleventh ... the following categories:, ,     Brand of the Year (BPI ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dental practice in Los ... in need. Most people know that general health emergencies, such as broken arms or ... of people know where to turn to during a dental emergency. This is important, ...
(Date:8/3/2015)... ... 03, 2015 , ... Social impact organization’s #HelpOneHelpMany approach recognized ... Since winning a South by Southwest® (SXSW®) Interactive Innovation Award in the Innovative ... is to develop technology for the sake of humanity – continues to receive ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novatus, Inc. today launched the ... as well as announced the date of its next major release. , Version ... management tasks as well as enhancements to the customer experience. Users now ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Novatus Unveils Milestone Software Release 2
... such as kidney failure and endocrine tumors are among ... the common pain relievers in your medicine cabinet be ... Tel Aviv University,s Sackler Faculty of Medicine and the ... are underlying causes of hypertension, which is a major ...
... Ariz. -- Scientists at Fred Hutchinson Cancer Research ... have discovered a literal ,break through, in pancreatic ... cancer tumors build around themselves have made them ... Hutchinson Center/TGen study published today in the highly-regarded ...
... (HealthDay News) -- Seeing a baby,s face triggers a response ... planning movement, a finding researchers say may indicate a natural ... this pattern in adults who didn,t know the baby and ... have no children of their own. Yet images of a ...
... New evidence links Alzheimer,s disease and diabetes , ... may be linked to insulin resistance, constituting a third ... observations including an increased risk of developing Alzheimer,s disease ... brain tissue of Alzheimer,s disease patients. Though intriguing, the ...
... muscles, and, more specifically, skeletal muscles that are controlled ... cylindrical muscle fibres with a multitude of peripheral nuclei. ... to position nuclei on the edge of muscle fibres. ... understand the reasons behind nuclei layout. Edgar ...
... , TUESDAY, March 20 (HealthDay News) -- The anti-inflammatory ... altitude sickness, according to a new study. Headache, ... the symptoms of altitude sickness, which affects more than ... each year to ski, hike or camp. If ...
Cached Medicine News:Health News:Pain relievers could be spiking your blood pressure 2Health News:Hutchinson Center and TGen scientists discover potential 'break through' in pancreatic cancer 2Health News:Infants' Faces Trigger Caregiving Impulse in Adults' Brains 2Health News:JCI early table of contents for March 26, 2012 2Health News:JCI early table of contents for March 26, 2012 3Health News:JCI early table of contents for March 26, 2012 4Health News:JCI early table of contents for March 26, 2012 5Health News:JCI early table of contents for March 26, 2012 6Health News:New discovery of proteins involved in positioning muscular nuclei 2Health News:Ibuprofen May Ward Off Altitude Sickness 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: